Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1979-08-01
1981-04-28
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
435238, A61K 3912
Patent
active
042645875
ABSTRACT:
A vaccine in parenteral dose form for preventing persistent feline leukemia viremia in cats is characterized by containing as the immunizing agent inactivated feline leukemia virus (FeLV) derived from the FL74 feline lymphoblastoid cell line.
REFERENCES:
patent: 3966907 (1976-06-01), Jarrett et al.
patent: 4034081 (1977-07-01), Jarrett et al.
patent: 4086134 (1978-04-01), Jarrett et al.
patent: 4117112 (1978-09-01), Jarrett et al.
Pedersen et al., Am. J. Vet. Res. 40 (8): 1120-1126, Aug. 1979 (copyright 1978), citing.
Jarrett et al., Int. J. Cancer 16: 134-141 (1975).
Jarrett et al., Nature 248: 230-232, (1976).
Yohn et al., Cancer Res. 36: 646-651 (1976).
Schaller et al., J. Natl. Cancer Inst. 59: 1441-1450 (1970).
Olsen et al., Cancer Res. 35: 3642-3646 (1976).
Olsen et al., Cancer Res. 37: 2082-2085 (1977).
Hoover et al., Infection and Immunity 16 (1): 54-59 Apr. 1977.
Salerno et al., P.S.E.B.M., 160: 18-23 (1979).
Pedersen Niels C.
Theilen Gordon H.
LandOfFree
Vaccine for preventing persistent feline leukemia viremia in cat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine for preventing persistent feline leukemia viremia in cat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine for preventing persistent feline leukemia viremia in cat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863964